ABBOTINDIA Stock Overview Operates as a pharmaceutical company in India. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Abbott India Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Abbott India Historical stock prices Current Share Price ₹29,957.25 52 Week High ₹30,521.00 52 Week Low ₹23,143.55 Beta 0.019 1 Month Change 5.33% 3 Month Change 6.59% 1 Year Change 27.10% 3 Year Change 59.98% 5 Year Change 135.66% Change since IPO 3,805.77%
Recent News & Updates Abbott India Limited Announces Resignation of Sridhar Kadangode as Whole Time Director and Director
Less than half of directors are independent Nov 13
Second quarter 2025 earnings released: EPS: ₹169 (vs ₹147 in 2Q 2024) Nov 08
Abbott India Limited Appoints Mr. Sridhar Kadangode as an Additional Director and as the Whole Time Director of the Company Nov 07
Abbott India Limited to Report Q2, 2025 Results on Nov 07, 2024 Oct 29
There's Reason For Concern Over Abbott India Limited's (NSE:ABBOTINDIA) Price Oct 17 See more updates Abbott India Limited Announces Resignation of Sridhar Kadangode as Whole Time Director and Director
Less than half of directors are independent Nov 13
Second quarter 2025 earnings released: EPS: ₹169 (vs ₹147 in 2Q 2024) Nov 08
Abbott India Limited Appoints Mr. Sridhar Kadangode as an Additional Director and as the Whole Time Director of the Company Nov 07
Abbott India Limited to Report Q2, 2025 Results on Nov 07, 2024 Oct 29
There's Reason For Concern Over Abbott India Limited's (NSE:ABBOTINDIA) Price Oct 17
Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt? Aug 31
Abbott India Limited Approves Final Dividend for Financial Year Ended March 31, 2024 Aug 09
Abbott India Limited to Report Q1, 2025 Results on Aug 07, 2024 Jul 30
Abbott India Limited Announces Resignation of Ashok Saini - Commercial Director - GenNext, Vaccines and Neurolife, Effective October 16, 2024 Jul 17
Less than half of directors are independent Jul 16
Full year 2024 earnings released: EPS: ₹565 (vs ₹447 in FY 2023) Jul 14
Abbott India (NSE:ABBOTINDIA) Has Announced That It Will Be Increasing Its Dividend To ₹410.00 Jul 13
Upcoming dividend of ₹410 per share Jul 12
Abbott India's (NSE:ABBOTINDIA) Upcoming Dividend Will Be Larger Than Last Year's Jun 27
Abbott India's (NSE:ABBOTINDIA) Shareholders Will Receive A Bigger Dividend Than Last Year Jun 13
Abbott India Limited Announces Resignation of Sabina Ewing as Director, Effective June 12, 2024 Jun 13
Abbott India (NSE:ABBOTINDIA) Is Paying Out A Larger Dividend Than Last Year May 12
Abbott India Limited, Annual General Meeting, Aug 08, 2024 May 12
Full year 2024 earnings released: EPS: ₹565 (vs ₹447 in FY 2023) May 11
Dividend increased to ₹410 May 11
Abbott India Limited Recommends Final Dividend for the Year Ended March 31, 2024, Payable on or After August 13, 2024 May 11
Abbott India Limited Recommends Final Dividend for the Year Ended March 31, 2024, Payable on or After August 13, 2024 May 10
Abbott India Limited Appoints Murari Ranganathan as Commercial Director Apr 12
Less than half of directors are independent Apr 11
Price target increased by 10% to ₹27,242 Mar 29
Abbott India Limited Announces Resignation of Sandeep Reddy - Commercial Director - Women's Health, Metabolics and International Business, with Effect from June 5, 2024 Mar 15
Is Abbott India (NSE:ABBOTINDIA) Using Too Much Debt? Feb 23
Abbott India Limited to Report Q3, 2024 Results on Feb 01, 2024 Jan 19
Abbott India Limited's (NSE:ABBOTINDIA) Business Is Yet to Catch Up With Its Share Price Jan 07 Abbott India Limited Announces Resignation of Vivek V Kamath as Managing Director, Effective from March 18, 2024
Second quarter 2024 earnings released: EPS: ₹147 (vs ₹125 in 2Q 2023) Nov 10
Abbott India Limited to Report Q2, 2024 Results on Nov 09, 2023 Nov 02
Abbott India Limited Approves Appointment of Sangeeta Shetty as Company Secretary, Effective September 14, 2023 Aug 10
New major risk - Earnings quality Aug 10
Abbott India Limited to Report Q1, 2024 Results on Aug 09, 2023 Jul 29
Abbott India Limited Appoints Ms Richa Tripathi as Associate Director, Effective August 3, 2023 Jul 25
Full year 2023 earnings released: EPS: ₹447 (vs ₹376 in FY 2022) Jul 18
Upcoming dividend of ₹325 per share at 1.4% yield Jul 14
Less than half of directors are independent Jul 04
Full year 2023 earnings released: EPS: ₹447 (vs ₹376 in FY 2022) May 21 Abbott India Limited, Annual General Meeting, Aug 09, 2023
Third quarter 2023 earnings released: EPS: ₹116 (vs ₹93.74 in 3Q 2022) Feb 12
Abbott India Limited to Report Q3, 2023 Results on Feb 10, 2023 Jan 31
Less than half of directors are independent Nov 16
Abbott India Limited to Report Q2, 2023 Results on Nov 14, 2022 Nov 05 Abbott India Limited Approves Final Dividend for the Financial Year Ended March 31, 2022
Abbott India Limited to Report Q1, 2023 Results on Aug 10, 2022 Jul 30
Upcoming dividend of ₹275 per share Jul 26
Full year 2022 earnings released: EPS: ₹376 (vs ₹325 in FY 2021) Jul 20
Abbott India Limited, Annual General Meeting, Aug 10, 2022 Jul 19
Full year 2022 earnings released: EPS: ₹376 (vs ₹325 in FY 2021) May 19 Abbott India Limited Recommends Special Dividend for the Year Ended March 31, 2022
Abbott India Limited to Report Q4, 2022 Results on May 17, 2022 May 07
Less than half of directors are independent Apr 27
Less than half of directors are independent Feb 16 Abbott India Limited Appoints Vivek V Kamath as Additional Director
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Feb 10
Abbott India Limited to Report Q3, 2022 Results on Feb 09, 2022 Feb 01
Price target increased to ₹19,998 Nov 16
Second quarter 2022 earnings released: EPS ₹90.51 (vs ₹85.05 in 2Q 2021) Nov 15
Upcoming dividend of ₹275 per share Jul 12
Full year 2021 earnings released: EPS ₹325 (vs ₹279 in FY 2020) Jul 06
Additional Non-Executive Director has left the company May 27
Abbott India Limited Recommends the Payment of Final Dividend for the Year Ended March 31, 2021, Payable on and After August 3, 2021 May 19
Full year 2021 earnings released: EPS ₹325 (vs ₹279 in FY 2020) May 19
Third quarter 2021 earnings released: EPS ₹83.36 (vs ₹87.85 in 3Q 2020) Feb 10
New 90-day low: ₹14,222 Jan 29
Abbott India Limited to Report Q3, 2021 Results on Feb 09, 2021 Jan 29
New 90-day low: ₹15,002 Jan 13
New 90-day low: ₹15,096 Nov 19 Shareholder Returns ABBOTINDIA IN Pharmaceuticals IN Market 7D 4.8% 3.1% 0.5% 1Y 27.1% 36.2% 17.4%
See full shareholder returns
Return vs Market: ABBOTINDIA exceeded the Indian Market which returned 17.4% over the past year.
Price Volatility Is ABBOTINDIA's price volatile compared to industry and market? ABBOTINDIA volatility ABBOTINDIA Average Weekly Movement 2.8% Pharmaceuticals Industry Average Movement 5.9% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.0% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: ABBOTINDIA has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: ABBOTINDIA's weekly volatility (3%) has been stable over the past year.
About the Company Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products.
Show more Abbott India Limited Fundamentals Summary How do Abbott India's earnings and revenue compare to its market cap? ABBOTINDIA fundamental statistics Market cap ₹636.23b Earnings (TTM ) ₹12.85b Revenue (TTM ) ₹60.66b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) ABBOTINDIA income statement (TTM ) Revenue ₹60.66b Cost of Revenue ₹33.43b Gross Profit ₹27.23b Other Expenses ₹14.39b Earnings ₹12.85b
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 604.57 Gross Margin 44.89% Net Profit Margin 21.18% Debt/Equity Ratio 0%
How did ABBOTINDIA perform over the long term?
See historical performance and comparison Dividends
1.4% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/02 19:43 End of Day Share Price 2025/01/02 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Abbott India Limited is covered by 16 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Abdulkader Puranwala Anand Rathi Shares and Stock Brokers Limited Shareen Batatawala Angel Broking Private Limited Rohit Bhat Batlivala & Karani Securities India Pvt. Ltd.
Show 13 more analysts 
